학술논문
975TiP Phase Ib trial of ABBV-368 + tilsotolimod in combination with nab-paclitaxel and/or budigalimab (ABBV-181) in patients with recurrent/metastatic head and neck squamous cell carcinoma
Document Type
Abstract
Author
Source
In Annals of Oncology September 2020 31 Supplement 4:S685-S685
Subject
Language
ISSN
0923-7534